phenylalanine has been researched along with Diabetic Retinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, ZZ; Feng, XF; Li, J; Luo, HH; Sun, XY; Yang, X | 1 |
| Akimoto, Y; Kawakami, H; Nagamatsu, S; Ohara-Imaizumi, M; Sawada, H | 1 |
| Do, DV; Gadek, TR; Gehlbach, P; Handa, JT; Nguyen, QD; Paskowitz, DM; Semba, C; Shaikh, O; Solomon, S; Stark, W | 1 |
1 trial(s) available for phenylalanine and Diabetic Retinopathy
| Article | Year |
|---|---|
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b study.
Topics: Adult; Aqueous Humor; Diabetic Retinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lymphocyte Function-Associated Antigen-1; Macular Edema; Male; Ophthalmic Solutions; Phenylalanine; Prospective Studies; Receptors, Lymphocyte Homing; Sulfones; Vitreous Body | 2012 |
2 other study(ies) available for phenylalanine and Diabetic Retinopathy
| Article | Year |
|---|---|
Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Phenylalanine; Tyrosine | 2020 |
Change in long-spacing collagen in Descemet's membrane of diabetic Goto-Kakizaki rats and its suppression by antidiabetic agents.
Topics: Animals; Collagen; Cornea; Cyclohexanes; Descemet Membrane; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glyburide; Hypoglycemic Agents; Immunohistochemistry; Male; Microscopy, Immunoelectron; Nateglinide; Phenylalanine; Rats; Rats, Inbred Strains; Rats, Wistar; Reference Values | 2008 |